ClinicalTrials.Veeva

Menu

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients (HEAL-Tx:ToC)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Enrolling

Conditions

Liver Transplant; Complications
Pediatric ALL

Treatments

Behavioral: Health Advocate

Study type

Interventional

Funder types

Other

Identifiers

NCT06386198
23-40699

Details and patient eligibility

About

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient has received a liver transplant >1 year ago
  2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
  3. Patient has an unmet social risk (e.g., food insecurity) or MLVI >/= 2.0.
  4. Patient will be transferred to adult transplant team in <6 months.
  5. Patient can read and write English or Spanish
  6. Patient is between 18-25 years old and can provide informed consent.
  7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.

Exclusion criteria

  • Patient has significant cognitive impairment.
  • Does not meet age criteria
  • Patient is a ward of the state.
  • Non-English, non-Spanish speakers.
  • Non-US residents.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Intervention
Experimental group
Description:
This is a single arm pilot intervention.
Treatment:
Behavioral: Health Advocate

Trial contacts and locations

2

Loading...

Central trial contact

Sharad Wadhwani, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems